Jth0.Mu
JTH0.MU operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
Business. JTH0.MU operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
JTH0.MU operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
JTH0.MU has a liquidity position that is moderate, with a current ratio of 2.81, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -2.88 million EUR, which suggests that capital expenditures are outpacing operating cash flow. The company's cash and equivalents amount to 14.08 million EUR, which is less than its long-term debt of 28.99 million EUR, resulting in a net cash position that is negative.
In terms of profitability, JTH0.MU's return on equity is 5.36%, and its return on assets is 2.46%, both of which are below the industry median for healthcare facilities and services. The company's operating income is 3.93 million EUR, and its net income is 2.05 million EUR, indicating a relatively low margin of profitability. The debt-to-equity ratio of 0.76 suggests a moderate level of leverage, which is in line with the industry norms.
JTH0.MU's revenue is not segmented by geographic regions or business lines in the provided data, so it is not possible to determine the geographic exposure or segment performance. The company's revenue concentration is not specified, and there is no information on the top customers or markets.
The company's growth trajectory is not clearly defined in the provided data, as there are no specific numeric deltas for the current or next fiscal year. The historical revenue data does not provide a clear trend, and there is no outlook provided for future revenue growth.
The risk assessment for JTH0.MU indicates a medium level of liquidity risk, with a current ratio of 2.81, and a low level of dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which could impact its ability to meet long-term obligations. The company has not disclosed any specific dilution sources, and there are no adjustments applied to the valuation metrics.
There are no recent events or filings provided in the data that would indicate significant changes in the company's operations or financial position. The company's transcripts and other disclosures do not appear to have been included in the provided data.
- JTH0.MU has a moderate liquidity position with a current ratio of 2.81.
- The company's profitability metrics, such as return on equity and return on assets, are below the industry median.
- JTH0.MU's free cash flow is negative, indicating that capital expenditures are outpacing operating cash flow.
- The company's debt-to-equity ratio is 0.76, suggesting a moderate level of leverage.
- There is no information on the company's geographic exposure or segment performance.
- The company's growth trajectory is not clearly defined, and there are no specific numeric deltas for the current or next fiscal year.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- JTH0.MU Market data — financials · 2026-05-28
Ownership & reference
Leadership
- Dietolf HaemelMember of the Management Board
- Gerhard ErtlChairman of the Supervisory Board